Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Interest & Investment Income (2016 - 2021)

Historic Interest & Investment Income for ImmunityBio (IBRX) over the last 7 years, with Q2 2021 value amounting to $112000.0.

  • ImmunityBio's Interest & Investment Income fell 6715.54% to $112000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $9.9 million, marking a year-over-year increase of 75789.47%. This contributed to the annual value of $1.2 million for FY2020, which is 2495.44% down from last year.
  • Per ImmunityBio's latest filing, its Interest & Investment Income stood at $112000.0 for Q2 2021, which was down 6715.54% from $8.9 million recorded in Q1 2021.
  • In the past 5 years, ImmunityBio's Interest & Investment Income ranged from a high of $8.9 million in Q1 2021 and a low of $78000.0 during Q1 2020
  • Moreover, its 5-year median value for Interest & Investment Income was $490500.0 (2018), whereas its average is $1.0 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 8097.56% in 2020, then soared by 1136666.67% in 2021.
  • Over the past 5 years, ImmunityBio's Interest & Investment Income (Quarter) stood at $817000.0 in 2017, then plummeted by 39.41% to $495000.0 in 2018, then crashed by 37.98% to $307000.0 in 2019, then skyrocketed by 42.67% to $438000.0 in 2020, then crashed by 74.43% to $112000.0 in 2021.
  • Its Interest & Investment Income was $112000.0 in Q2 2021, compared to $8.9 million in Q1 2021 and $438000.0 in Q4 2020.